Delpharm Gets $60M Federal Investment To Modernize Its Manufacturing Facility - Canadian Manufacturing

The French multinational Delpharm wants to expand and modernize its injection drug manufacturing plant in Boucherville. This 220 million-dollar project will run over almost six years.

Delpharm plans $140m investment to upgrade Boucherville facility

The investment also comprises C$60m in funding from the Canadian federal government. Delpharm will manufacture sterile injectable drugs at the Boucherville site and bolster its local supply chain. The The post Delpharm plans $140m investment to upgrade Boucherville facility in Canada appeared first on Pharmaceutical Business review.

Delpharm, the largest drug manufacturer in Canada, has announced a project of more than $200 million to modernize its production plant in Boucherville, which aims to strengthen the supply chain of sterile injectable drugs, and to preserve more than 500 highly qualified jobs in Quebec. The Boucherville plant is considered a key facility for the Canadian health care system, currently produces 20 of the 100 critical drugs for the country, used in p…

The modernization and expansion of Delpharm will help maintain the 500 current jobs in the region and increase the number of jobs in the region.The [...] L的article Investment of $60M from Canada at Delpharm in Boucherville appeared first on FM 103.3.

Delpharm Gets $60M Federal Investment To Modernize Its Manufacturing Facility - Canadian Manufacturing

BOUCHERVILLE — Delpharm is modernizing its injectable manufacturing facility in Boucherville, Quebec, with the help of $60 million in funding from the federal government. The Boucherville plant currently produces 20 of the 100 critical medicines. Delpharm also signed a 10-year, long-term supply agreement with Sandoz Canada. This modernization plan represents a total investment exceeding $200 million and will preserve over 500 skilled jobs in Que…